MEETING PROSPECTUS - Virology Educationregist2.virology-education.com/Sponsorship_Request/2018/Transmission.pdf · International workshop on HIV Transmission 2018 - Meeting Prospectus

www.expertmedicalevents.comwww.virology-education.com

MEETING PROSPECTUS

13TH INTERNATIONAL WORKSHOP ON

AMSTERDAM, THE NETHERLANDS • 21-22 JULY 2018 TBC

HIV TRANSMISSION PRINCIPLES OF INTERVENTION

ADVANCING HEALTH

GLOBALLY THROUGH

INNOVATIVE PROGRAMS

DESIGNED FOR THE

HEALTHCARE PROFESSIONAL

International workshop on HIV Transmission 2018 - Meeting Prospectus 3

TABLE OF CONTENTS

Welcome 4

Meeting description 5

Needs assessment 5

Target audience 5

Program description 5

Meeting objectives 5

Accreditation 5

Learning outcomes 6

Assessment method 6

Conference participation grants 7

Enduring materials 7

Committees 8

Infographics 2016 edition 10

Acknowedgements 11

International workshop on HIV Transmission 2018 - Meeting Prospectus4

NEEDS STATEMENT

Over the years, advances in HIV treatment have led to an enhanced understanding of the virus and improved care of HIV infected patients. However our insights into the spread of the HIV virus remain limited. A more extensive exchange of knowledge on the various aspects of HIV transmission provides important perspectives for a better approach to the epidemic. For this purpose, an integrated forum was set up in 2006 to reveal perspectives of experts from different fields enabling discussion on all relevant mechanisms of HIV transmission. The annual Transmission Workshops have since continued to prove themselves valuable to those specialized (or specializing) in HIV transmission.

The main objectives of this meeting are to provide a forum for basic scientists, clinicians, virologists, epidemiologists and public health officials to present and to discuss the various aspects of the transmission of HIV. The ultimate goal of the meeting is the integration of efforts from all relevant disciplines in order to constrain the spread of (drug-resistant) HIV.

TARGET AUDIENCE

The target audience of this meeting consists of all those who are actively involved in or interested in HIV Transmissions such as Clinicians, Virologists, Epidemiologists, Public health officials, Industry representatives, Social workers, advocates and community workers, Other healthcare professionals involved in treating HIV an co-infected patients.

PROGRAM DESCRIPTION This will be a 2-day meeting consists of invited lectures and roundtable discussions. The meeting also includes abstract- driven presentations. In order to ascertain an interactive workshop there is time for discussion with ample time being allocated for Q&A.

Being an abstract driven meeting, it is an excellent platform for (young) investigators to present their research. To ensure the quality of the accepted abstracts, all submitted abstracts shall go through a peer-reviewed process conducted by the members of the Organizing and Scientific Committees.

MEETING OBJECTIVES

• International workshop for basic scientists, clinicians, virologists, epidemiologists and public health officials to present and discuss the various aspects of the transmission of HIV.

• Platform for the integration of efforts from all relevant disciplines in order to constrain the spread of (drug-resistant) HIV.

• Research discussion forum on various aspects of transmission from basic science (e.g. in vitro models) to clinical management of HIV (e.g. transmission chain analysis)

ACCREDITATION

This workshop will not be a CME accredited activity.

MEETING DESCRIPTION


MEETING DESCRIPTION

LEARNING OUTCOMES & IMPACT

After attending this program participants will be able:

• Enhanced communication and collaboration between both junior- and senior-level, international researchers (from academia, government, and industry) and clinicians to promote the exchange of ideas, results, and technologies leading to successful translation into prevention of HIV/AIDS.

• Dissemination of knowledge and data exchanged by conference participants beyond the audience of the live event, thus maximizing the impact for the growing biology of HIV research community.

ASSESSMENT METHOD

To assess the meeting, Virology Education provides each delegate with a detailed feedback form where they can assess the speakers, whether or not the meeting objectives were met, their intent to change, the rationale behind their motivation to attend, the general logistics of the meeting, and much more.

All the questions are then fully analyzed and a comprehensive report is created and shared with the committee members. These reports help us better understand our delegates and how to make the next meeting better.

For a maximum response rate, we invite the chairs of each session to encourage the participants to take a few minutes and complete the feedback forms. We are also introducing a web-based application to allow participants access to the feedback forms electronically.


CONFERENCE PARTICIPATION GRANTS

The conference participation grants provide healthcare professionals with the opportunity to attend a conference they would otherwise be unable to attend due to financial restrictions. All applications include a CV, a motivation letter, and potentially an abstract (requirements vary depending on the workshop). These are submitted via an independent CPG portal and are evaluated against the assessment criteria using robust, impartial and independent peer review processes by the Grant Review Committee. This process will ensure that only the highest quality, most relevant and most competitive research is accepted but that it is.

The grants are supported by the financial contributions allocated by the sponsor, who, has no control, influence, or involvement in the selection process of the attendees whatsoever. Priority is given to applicants who have actively participated in original research

or scientific work that is being presented at the meeting and/or those who will profit most from participating in order to improve their daily clinical management.

These grants help defray costs for registration, travel and accommodation for delegates and foster their ability to form valuable professional networks and develop vital collaborations. Conference participation grant applications will be solicited, selected and awarded by an expert Grant Review Committee.

Please note that the TITANIUM, PLATINUM and GOLD support levels will reduce the costs for conference participation grants. Supporters can indicate a desired number of CPGs to be granted in the response form further below.

ENDURING MATERIALSINFECTIOUS DISEASES ONLINEEnduring information presented at the conference will be freely retrievable and widely disseminated to reach thousands of virtual participants beyond the walls of the conference center. Infectious Diseases Online is a premier online platform offering scientific materials in special topical areas and proceedings of conferences. By accessing the website, visitors have full access to:

• Abstract Books

• Meeting Reports

• Workshop Presentations

• Webcasts

All the data on Infectious Diseases Online is organized by workshop and date, making the materials highly organized and easy to find. The meeting proceedings will also be published on the meeting website.


COMMITTEES

ORGANIZING COMMITTEE

Walid Heneine PhD

Centers for Disease Control and Prevention, USA

Phyllis Kanki DVM, DSC

Harvard School of Public Health, USA

Charles Boucher MD, PhD

Erasmus Medical Center, The Netherlands

Eric Arts PhD,

Western University, Canada

Thomas Hope PhD

Northwestern University Feinberg School of Medicine

USA

Myron Cohen MD

University of North Carolina,

USA

Eric Hunter PhD

Emory University, USA

Jan Albert MD,

Karolinska Institute the Sweden

IVHEM


COMMITTEES

ORGANIZING COMMITTEE

Carolyn Williamson PhD

University of Cape Town, South Africa

Annemarie WensingMD, PhD

University Medical Center Utrecht,

The Netherlands

Ronald Swanstrom PhD,

University of North Carolina,

USA

Bonnie Mathieson PhD

National Institutes of Health,

USA

Gabriella Sarlatti PhD

Global HIV Vaccine Enterprise,

USA

Christiane Moog MD

INSERM U1109 France

L. Jean Patterson PhD

National Institutes of Health,

USA

IVHEM


SCIENTIFIC COMMITTEE

Stephen Becker, MD - Bill & Melinda Gates Foundation, USA

Sally Blower, PhD - University of Los Angeles, USA

Max Essex, PhD - Harvard T.H. Chan School of Public Health, USA

Robert Grant, MD, PhD - University of California, USA

Yasmin Halima, MPH - EQUIP/ Right to Care, South Africa

David Hawkins, MD - Chelsea and Westminster Hospital UK

Sharon Hillier, PhD - Magee Womens Hospital UPMC, USA

Patrick Kiser, PhD - Northwestern University, USA

Roger Legrand, Commissariat á l'Energie Atomique, France

Susan Little, MD - University of California, USA

Sheena McCormack, MD - MRC Clinical Trials Unit, UK

Michaela Müller-Trutwin - Pasteur Institute, France

Jim Mullins, PhD - University of Washington, USA

Helen Rees, MD - University of the Witwatersrand, Johannesburg, South Africa

Merlin Robb - Henry M. Jackson Foundation, USA

Asier Siron Saez - Pasteur Institute, France

Robin Shattock - Imperial College, UK

Christiane Stahl-Hennig, Deutsches Primatenzentrum GmbH, Germany


INFOGRAPHICS 2016 EDITION

RETURNING PARTICIPANTS

MEETING OBJECTIVES

COUNTRIESOCCUPATION

WORKPLACE TYPE

The majority of the 80 delegates that attended the previous Transmission Workshop worked as researcher (68%), or medical doctor (18%).

67% of participants (n=42) attended more than one the the workshop.

80 delegates from 12 differ-ent countries participated in 2016. Most delegates were from USA (70%), but also UK (7%), Canada (6%), were represented.

The majority of the 80 delegates attending the Transmission Workshop worked for a university. Others were employed by an government, NGO, hospital, or other.

Below is indicated to what extent participants indicated that the meeting objectives were met.

1 This meeting enhances the integration from all relevant disciplines to constrain the spread of (drug-resistant) HIV.

2 This meeting provides a forum to discuss the various aspects of the transmission of HIV

98%

100%

Medical doctor (MD)Researcher Other

68% 18% 14%

University; (N=51); 64%

Government; (N=21); 26%

NGO(N=4); 5%

Hospital(N=2); 2%

Other(N=2); 3%


ACKNOWLEDGEMENTS

SPONSORS

PLATINUM LEVEL

SILVER LEVEL

CONTRIBUTOR LEVEL


MEETING PARTNERS

ACKNOWLEDGEMENTS


FOR MORE INFORMATION, PLEASE CONTACT US AT:

VIROLOGY EDUCATION

Biltstraat 106

3572 BJ Utrecht

the Netherlands

www.virology-education.com

[email protected]

+31 30 230 7140

Documents

MEETING PROSPECTUS - Virology Educationregist2.virology-education.com/Sponsorship_Request/2018/Transmission.pdf · International workshop on HIV Transmission 2018 - Meeting Prospectus